Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of Groningen
- Amsterdam UMC
- Radboud University
- Amsterdam UMC; 27 Sep ’25 published
- Delft University of Technology (TU Delft)
- Delft University of Technology (TU Delft); yesterday published
- Eindhoven University of Technology (TU/e)
- KNAW
- Maastricht University (UM)
- Maastricht University (UM); 26 Sep ’25 published
- University of Amsterdam (UvA)
- University of Amsterdam (UvA); 26 Sep ’25 published
- University of Groningen; Groningen
- University of Twente
- University of Twente (UT)
- University of Twente (UT); Enschede
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- Wageningen University & Research
- 9 more »
- « less
-
Field
-
-subject clinical and pathological information with morphological and molecular knowledge of induced pluripotent stem cells (iPSC) of PD(D)/DLB patients to identify molecular profiles and drug targets. We
-
dilemma that hampers drug development, here, we implemented a translational approach that integrates within-subject clinical and pathological information with morphological and molecular knowledge
-
Postdoc in Extracellular Vesicles as Mediators of Gut-Microbiome Interactions in Parkinson's Disease
to ileostomy samples, Parkinson’s disease cohorts, and novel hydrogel/motility models. This approach allows us to reveal microbial processes that are difficult to capture with standard models, connecting patient
-
tracers. Specifically, you will use clinical molecular imaging data in combination with numerous methods (i.e., AI image analyses, PBPK modeling, immunohistochemistry, FACS). As a postdoctoral researcher
-
of RNA therapeutics for the brain. The successful candidate will work at the interface of molecular biology, cell models of the blood–brain barrier, and advanced human in vitro systems such as induced
-
Postdoc in Extracellular Vesicles as Mediators of Gut-Microbiome Interactions in Parkinson's Disease
microbiome function in health and disease. We focus on the small intestine (ileum) and colon, using access to ileostomy samples, Parkinson’s disease cohorts, and novel hydrogel/motility models. This approach
-
You will develop and validate advanced AI models that integrate medical imaging, multi-modal clinical and omics data, and explainable AI (XAI) for the prediction of hepatocellular carcinoma (HCC
-
work at the interface of molecular biology, cell models of the blood–brain barrier, and advanced human in vitro systems such as induced pluripotent stem cell (iPSC)-derived cultures and organoids. A key
-
aging-associated mechanisms and the development of RNA therapeutics for the brain. The successful candidate will work at the interface of molecular biology, cell models of the blood–brain barrier, and
-
Molecular and Cellular Neurobiology (MCN) . Recent studies have shown that in addition to neurons, glial cells play a major role in synaptic function. As yet, it is unclear what the molecular mechanisms